Learning Objectives
- Outline differences between neonatal seizures and seizures at other ages
- Explain the relationship between neonatal seizures and adverse neurodevelopmental outcomes
- Make a distinction between presence of neonatal seizures and seizure burden
- Describe potential adverse effects of phenobarbital exposure in the neonatal period
- Summarize data from previous studies supporting the efficacy of phenobarbital and levetiracetam
- Compare data from previous studies to outcomes of patients treated for neonatal seizures at UW
Evaluation
Click here to complete today’s evaluation: https://ce.icep.wisc.edu/neurology-grand-rounds-20-22-eval-15135
Session date:
05/17/2021 - 4:00pm to 5:00pm CDT
Location:
Medical Foundation Centennial Bldg, Room #1220
1685 Highland Ave
Madison, WI
53705
United States
See map: Google Maps
- 1.00 AMA PRA Category 1 Credit™
- 1.00 University of Wisconsin–Madison Continuing Education Hours
Add to calendar:
Discloser List CME Internal Report
Presenter(s):
Andrew Knox, MD